Publication Venue For
Genome-Wide Association Study of Apparent Treatment-Resistant Hypertension in the CHARGE Consortium: The CHARGE Pharmacogenetics Working Group.
Ethnic differences in nighttime melatonin and nighttime blood pressure: A study in European Americans and African Americans.
Cardioprotective Effects of Paricalcitol Alone and in Combination with FGF23 Receptor Inhibition in Chronic Renal Failure: Experimental and Clinical Studies.
Health Behaviors, Nocturnal Hypertension, and Non-dipping Blood Pressure: The coronary artery risk development in young adults and jackson Heart study.
Serum Sodium and Pulse Pressure in SPRINT.
Long-term effects of an intensive lifestyle intervention on electrocardiographic criteria for left ventricular hypertrophy: The look AHEAD trial.
West African ancestry and nocturnal blood pressure in African Americans: The Jackson Heart Study.
Use of Aldosterone Antagonists for Treatment of Uncontrolled Resistant Hypertension.
11-beta dehydrogenase type 2 activity is not reduced in treatment resistant hypertension.
Cumulative exposure to systolic blood pressure during young adulthood through midlife and the urine albumin-to-creatinine ratio at midlife.
Effects of spironolactone and renal denervation treatment on blood pressure and its variability-different aspects of hypertension treatment.
Psychosocial Correlates of Nocturnal Blood Pressure Dipping in African Americans: The Jackson Heart Study.
Potential Errors and Omissions Related to the Analysis and Conclusions Reported in Cuspidi C, et al., AJH 2014; 27(2):146-156.
Prehypertension Is Associated With Abnormalities of Cardiac Structure and Function in the Atherosclerosis Risk in Communities Study.
Clock genes explain a large proportion of phenotypic variance in systolic blood pressure and this control is not modified by environmental temperature.
Is isolated nocturnal hypertension a reproducible phenotype?.
Systolic blood pressure control among individuals with type 2 diabetes: A comparative effectiveness analysis of three interventions.
Is pulse pressure an independent risk factor for incident stroke, REasons for geographic and racial differences in stroke.
Nocturnal blood pressure in young adults and cognitive function in midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) study.
Racial differences in abnormal ambulatory blood pressure monitoring measures: Results from the coronary artery risk development in young adults (CARDIA) study.
Prehypertension and incident acute coronary heart disease in the reasons for geographic and racial differences in stroke (Regards) study.
Achieved blood pressures in the secondary prevention of small subcortical strokes (SPS3) study: Challenges and lessons learned.
Hemodynamic and echocardiographic profiles in african american compared with white offspring of hypertensive parents: The HyperGEN study.
Is pulse pressure an independent risk factor for incident acute coronary heart disease events? the REGARDS study.
Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats.
Blood pressure after recent stroke: Baseline findings from the secondary prevention of small subcortical strok.
Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease.
Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension.
Moderate waist circumference and hypertension prevalence: The REGARDS study.
Prehypertension, racial prevalence and its association with risk factors: Analysis of the reasons for geographic and racial differences in stroke (REGARDS) study.
Adjusting adiposity and body weight measurements for height alters the relationship with blood pressure in children.
The association of cell cycle checkpoint 2 variants and kidney function: Findings of the family blood pressure program and the atherosclerosis risk in communities study.
Prenatal programming: Maybe not so hopeless after all?.
Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension.
A summary of the effects of antihypertensive medications on measured blood pressure.
A unifying pathway for essential hypertension.
Role of angiotensin receptor blockers as monotherapy in reaching blood pressure goals.
Genome-wide linkage analyses for age at diagnosis of hypertension and early-onset hypertension in the HyperGEN study.
Determinants of radial artery pulse wave analysis in asymptomatic individuals.
Advanced glycation end-product cross-link breakers: A novel approach to cardiovascular pathologies related to the aging process.
Genome scan for hypertension in nonobese African Americans: The National Heart, Lung, and Blood Institute Family Blood Pressure Program.
Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events.
A Genome-Wide Linkage Analysis Investigating the Determinants of Blood Pressure in Whites and African Americans.
Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension.
Excess dietary glucose alters renal function before increasing arterial pressure and inducing insulin resistance.
Are there meaningful differences in blood pressure control with current antihypertensive agents?.
Obesity: Its time has come.
Arterial compliance abnormalities in isolated systolic hypertension.
Urinary excretion of vasoactive factors are correlated to sodium excretion.
Elevated potassium intake inhibits neointimal proliferation in the swine coronary artery.
Cardiovascular effects of estrogen..
The role of the central nervous system in NaCl-sensitive hypertension in spontaneously hypertensive rats..
Blood pressure and arterial compliance in young adults: The Minnesota Children's Blood Pressure Study.
Factors affecting blood pressure responses to diet: The vanguard study.
High potassium intake inhibits neointima formation in the rat carotid artery balloon injury model.
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: The life study.
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint..
Insulin and hypertension in the NHLBI family heart study.
Newly emerging pharmacologic differences in angiotensin II receptor blockers.
Newly emerging pharmacologic differences in angiotensin II receptor blockers..
Treating multiple-risk hypertensive populations..
Fenoldopam: A new parenteral antihypertensive: Consensus roundtable on the management of perioperative hypertension and hypertensive crises.
A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension.
A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension..
Management of the hypertensive patient with coronary artery disease..
Management of the hypertensive patient with coronary artery disease.
Treating multiple-risk hypertensive populations.
The evolving role of angiotensin-II receptor blockers in cardiovascular risk reduction. Case study..
Mibefradil, a T-channel-selective calcium antagonist: clinical trials in hypertension..
Comprehensive nutrition plan improves cardiovascular risk factors in essential hypertension.
Comprehensive nutrition plan improves cardiovascular risk factors in essential hypertension..
Mibefradil, a T-channel-selective calcium antagonist: Clinical trials in hypertension.
Vascular compliance and cardiovascular disease: A risk factor or a marker?.
Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension.
Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension..
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group..
ALLHAT and calcium channel blockers .
ALLHAT and calcium channel blockers. ALLHAT Research Group..
Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients.
Erratum: Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension (American Journal of Hypertension (July 1997) 10 (735-742)).
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study rationale, design, and methods.
Lack of independent relationships between left ventricular mass and cardiovascular reactivity to physical and psychological stress in the coronary artery risk development in young adults (CARDIA) study.
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group..
Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT).
Pressor and bradykardie effects of centrally administered relaxin in conscious rats.
Effects of acute and chronic blockade of neutral endopeptidase with Sch 34826 on NaCl-sensitive hypertension in spontaneously hypertensive rats..
Effects of acute and chronic blockade of neutral endopeptidase with sch 34826 on nacl-sensitive hypertension in spontaneously hypertensive rats.
Ganglion atrial natriuretic peptide in nacl sensitive spontaneously hypertensive rats.
The calcium antagonists in the 1990s. An overview..
Altered stores of atrial natriuretic peptide in specific brain nuclei of NaCl-sensitive spontaneously hypertensive rats..
Altered stores of atrial natriuretic peptide in specific brain nuclei of nacl-sensitive spontaneously hypertensive rats.
Diagnosis of renovascular hypertension after renal transplantation.
Report of the working party group on determining the radionuclide of choice.
The calcium antagonists in the 1990s an overview.
Dietary Ca2+ prevents NaCl-sensitive hypertension in spontaneously hypertensive rats by a sympatholytic mechanism..
Dietary ca2+prevents NaCl-sensitive hypertension in spontaneously hypertensive rats by a sympatholytic mechanism.
Central mechanisms of hypertension..
Dietary NaCl loading enhances antihypertensive effect of guanabenz in spontaneously hypertensive rats..
Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertension..
Central mechanisms of hypertension.
Dietary NaCl loading enhances antihypertensive effect of guanabenz in spontaneously hypertensive rats.
Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertension.